New therapies for asthma: is there any progress?
- 1 July 2010
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 31 (7) , 335-343
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- Targeting Phosphoinositide-3-Kinase-δ with Theophylline Reverses Corticosteroid Insensitivity in Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Dual PDE3/4 inhibitors as therapeutic agents for chronic obstructive pulmonary diseaseBritish Journal of Pharmacology, 2009
- Peptide immunotherapy in allergic asthma generates IL-10–dependent immunological tolerance associated with linked epitope suppressionJournal of Experimental Medicine, 2009
- Suppression of GATA-3 Nuclear Import and Phosphorylation: A Novel Mechanism of Corticosteroid Action in Allergic DiseasePLOS Medicine, 2009
- Ligation of TLR9 induced on human IL-10–secreting Tregs by 1α,25-dihydroxyvitamin D3 abrogates regulatory functionJournal of Clinical Investigation, 2009
- The cytokine network in asthma and chronic obstructive pulmonary diseaseJournal of Clinical Investigation, 2008
- Immunology of asthma and chronic obstructive pulmonary diseaseNature Reviews Immunology, 2008
- Inhaled iloprost suppresses the cardinal features of asthma via inhibition of airway dendritic cell functionJournal of Clinical Investigation, 2007
- Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell functionJournal of Clinical Investigation, 2006
- How corticosteroids control inflammation: Quintiles Prize Lecture 2005British Journal of Pharmacology, 2006